A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06560138 · WITHDRAWN

Trial details

NCT number: NCT06560138
Sponsor: Atridia Pty Ltd.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors

Start date: 2025-03-01
Primary completion: 2025-12-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.